Glen Baker - Publications

Affiliations: 
Neuroscience and Mental Health Institute University of Alberta, Edmonton, Alberta, Canada 

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Ahn KC, Learman CR, Baker GB, Weaver CL, Chung PS, Kim HG, Song MS. Regulation of Diabetes: a Therapeutic Strategy for Alzheimer's Disease? Journal of Korean Medical Science. 34: e297. PMID 31779058 DOI: 10.3346/jkms.2019.34.e297  0.423
2019 Baker G, Matveychuk D, MacKenzie EM, Holt A, Wang Y, Kar S. Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine. Chemico-Biological Interactions. PMID 30857888 DOI: 10.1016/J.Cbi.2019.03.003  0.325
2019 Dhami KS, Churchward MA, Baker GB, Todd KG. Fluoxetine and its metabolite norfluoxetine induce microglial apoptosis. Journal of Neurochemistry. PMID 30613984 DOI: 10.1111/Jnc.14661  0.688
2018 Ahn KC, Baker GB, Jang WC, Cha HC, Moon MJ, Song MS. Roles of 5-HT on phase transition of neurite outgrowth in the identified serotoninergic neuron C1, Helisoma trivolvis. Invertebrate Neuroscience : In. 18: 10. PMID 30128715 DOI: 10.1007/s10158-018-0214-6  0.454
2018 Potter LE, Doolen S, Mifflin K, Tenorio G, Baker G, Taylor BK, Kerr BJ. Antinociceptive effects of the antidepressant phenelzine are mediated by context-dependent inhibition of neuronal responses in the dorsal horn. Neuroscience. PMID 29752984 DOI: 10.1016/J.Neuroscience.2018.04.047  0.306
2017 Raitsin S, Tong J, Kish S, Xu X, Magomedova L, Cummins C, Andreazza AC, Scola G, Baker G, Meyer JH. Subchronic Glucocorticoids, Glutathione Depletion and a Postpartum Model Elevate Monoamine Oxidase A Activity in the Prefrontal Cortex of Rats. Brain Research. PMID 28435083 DOI: 10.1016/J.Brainres.2017.03.032  0.34
2016 Alles SR, Bandet MV, Eppler K, Noh MC, Winship IR, Baker G, Ballanyi K, Smith PA. Acute anti-allodynic action of gabapentin in dorsal horn and primary somatosensory cortex: Correlation of behavioural and physiological data. Neuropharmacology. PMID 27856391 DOI: 10.1016/J.Neuropharm.2016.11.011  0.647
2013 Dhami KS, Churchward MA, Baker GB, Todd KG. Fluoxetine and citalopram decrease microglial release of glutamate and D-serine to promote cortical neuronal viability following ischemic insult. Molecular and Cellular Neurosciences. 56: 365-74. PMID 23876875 DOI: 10.1016/J.Mcn.2013.07.006  0.681
2011 Ramachandraih CT, Subramanyam N, Bar KJ, Baker G, Yeragani VK. Antidepressants: From MAOIs to SSRIs and more. Indian Journal of Psychiatry. 53: 180-2. PMID 21772661 DOI: 10.4103/0019-5545.82567  0.359
2004 Salsali M, Holt A, Baker GB. Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6. Cellular and Molecular Neurobiology. 24: 63-76. PMID 15049511 DOI: 10.1023/B:Cemn.0000012725.31108.4A  0.724
2004 Fletcher PJ, Sinyard J, Salsali M, Baker GB. Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects. Psychopharmacology. 174: 406-13. PMID 14740149 DOI: 10.1007/S00213-003-1747-9  0.714
2003 Asghar SJ, Tanay VAMI, Baker GB, Greenshaw A, Silverstone PH. Relationship of plasma amphetamine levels to physiological, subjective, cognitive and biochemical measures in healthy volunteers Human Psychopharmacology. 18: 291-299. PMID 12766934 DOI: 10.1002/hup.480  0.475
2001 Tanay VM, Greenshaw AJ, Baker GB, Bateson AN. Common effects of chronically administered antipanic drugs on brainstem GABA(A) receptor subunit gene expression. Molecular Psychiatry. 6: 404-12. PMID 11443524 DOI: 10.1038/Sj.Mp.4000879  0.482
2001 Parent M, Bush D, Rauw G, Master S, Vaccarino F, Baker G. Analysis of amino acids and catecholamines, 5-hydroxytryptamine and their metabolites in brain areas in the rat using in vivo microdialysis. Methods (San Diego, Calif.). 23: 11-20. PMID 11162146 DOI: 10.1006/Meth.2000.1102  0.307
2000 Salsali M, Coutts RT, Baker GB. A rapid electron-capture gas chromatographic procedure for the analysis of p-hydroxymephenytoin Journal of Pharmacological and Toxicological Methods. 44: 461-465. PMID 11395323 DOI: 10.1016/S1056-8719(01)00113-7  0.721
2000 Sills TL, Greenshaw AJ, Baker GB, Fletcher PJ. Subchronic fluoxetine treatment induces a transient potentiation of amphetamine-induced hyperlocomotion: possible pharmacokinetic interaction. Behavioural Pharmacology. 11: 109-16. PMID 10877115 DOI: 10.1097/00008877-200004000-00002  0.516
2000 Urichuk LJ, Allison K, Holt A, Greenshaw AJ, Baker GB. Comparison of neurochemical effects of the monoamine oxidase inhibitors phenelzine, moclobemide and brofaromine in the rat after short- and long-term administration. Journal of Affective Disorders. 58: 135-44. PMID 10781703 DOI: 10.1016/S0165-0327(99)00105-6  0.529
1999 Salsali M, Coutts RT, Baker GB. Analysis of dextrorphan, a metabolite of dextromethorphan, using gas chromatography with electron-capture detection Journal of Pharmacological and Toxicological Methods. 41: 143-146. PMID 10691018 DOI: 10.1016/S1056-8719(99)00033-7  0.727
1999 Sills TL, Greenshaw AJ, Baker GB, Fletcher PJ. The potentiating effect of sertraline and fluoxetine on amphetamine-induced locomotor activity is not mediated by serotonin. Psychopharmacology. 143: 426-32. PMID 10367561 DOI: 10.1007/S002130050968  0.513
1999 Sills TL, Greenshaw AJ, Baker GB, Fletcher PJ. Acute fluoxetine treatment potentiates amphetamine hyperactivity and amphetamine-induced nucleus accumbens dopamine release: possible pharmacokinetic interaction. Psychopharmacology. 141: 421-7. PMID 10090650 DOI: 10.1007/S002130050852  0.498
1998 Choi K-, Baker GB, Greenshaw AJ. EFFECTS OF AMPA/KA RECEPTOR BLOCKADE ON D1 AND D2-LIKE DA RECEPTOR MEDIATED EFFECTS IN NAS CORE AND SHELL Behavioural Pharmacology. 9: S24. DOI: 10.1097/00008877-199808000-00035  0.436
1996 Tanay VA, Glencorse TA, Greenshaw AJ, Baker GB, Bateson AN. Chronic administration of antipanic drugs alters rat brainstem GABAA receptor subunit mRNA levels. Neuropharmacology. 35: 1475-82. PMID 9014163 DOI: 10.1016/S0028-3908(96)00065-2  0.485
1996 McGregor A, Baker G, Roberts DC. Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on intravenous cocaine self-administration under a progressive ratio schedule of reinforcement. Pharmacology, Biochemistry, and Behavior. 53: 5-9. PMID 8848459 DOI: 10.1016/0091-3057(95)00192-1  0.3
1994 Goodnough DB, Baker GB, Mousseau DD, Greenshaw AJ, Dewhurst WG. Effects of low- and high-dose tranylcypromine on [3H]tryptamine binding sites in the rat hippocampus and striatum. Neurochemical Research. 19: 5-8. PMID 8139763 DOI: 10.1007/Bf00966720  0.445
1994 Sherry-McKenna RL, Wong JT, Paetsch PR, Baker GB, Mousseau DD, McKenna KF, Coutts RT, Greenshaw AJ. Monoamine oxidase inhibitors: effects on tryptophan concentrations in rat brain. Journal of Neural Transmission. Supplementum. 41: 155-63. PMID 7931222 DOI: 10.1007/978-3-7091-9324-2_22  0.518
1993 Mousseau DD, McManus DJ, Baker GB, Juorio AV, Dewhurst WG, Greenshaw AJ. Effects of age and of chronic antidepressant treatment on [3H]tryptamine and [3H]dihydroalprenolol binding to rat cortical membranes. Cellular and Molecular Neurobiology. 13: 3-13. PMID 8384528 DOI: 10.1007/Bf00712985  0.465
1993 Paetsch PR, Baker GB, Greenshaw AJ. Induction of functional down-regulation of beta-adrenoceptors in rats by 2-phenylethylamine. Journal of Pharmaceutical Sciences. 82: 22-4. PMID 8381487 DOI: 10.1002/Jps.2600820105  0.491
1993 Allison K, Paetsch PR, Baker GB, Greenshaw AJ. Chronic antidepressant drug treatment attenuates motor-suppressant effects of apomorphine without changing [3H]GBR 12935 binding. European Journal of Pharmacology. 249: 125-31. PMID 8287894 DOI: 10.1016/0014-2999(93)90424-G  0.521
1992 McManus DJ, Baker GB, Martin IL, Greenshaw AJ, McKenna KF. Effects of the antidepressant/antipanic drug phenelzine on GABA concentrations and GABA-transaminase activity in rat brain. Biochemical Pharmacology. 43: 2486-9. PMID 1610412 DOI: 10.1016/0006-2952(92)90331-C  0.477
1992 Paetsch PR, Baker GB, Caffaro LE, Greenshaw AJ, Rauw GA, Coutts RT. Electron-capture gas chromatographic procedure for simultaneous determination of amphetamine and N-methylamphetamine. Journal of Chromatography. 573: 313-7. PMID 1601966 DOI: 10.1016/0378-4347(92)80135-D  0.494
1992 McKenna KF, Baker GB, Coutts RT, Greenshaw AJ. Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function. Journal of Pharmaceutical Sciences. 81: 832-5. PMID 1383493 DOI: 10.1002/Jps.2600810823  0.52
1990 Wong JT, Paetsch PR, Baker GB, Greenshaw AJ, Coutts RT. A rapid procedure for the analysis of phenylalanine in brain tissue utilizing electron-capture gas chromatography. Journal of Neuroscience Methods. 32: 105-9. PMID 2366572 DOI: 10.1016/0165-0270(90)90165-C  0.488
1989 Baker GB, Greenshaw AJ. Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system. Cellular and Molecular Neurobiology. 9: 1-44. PMID 2565769 DOI: 10.1007/BF00711441  0.468
1989 Greenshaw AJ, Rao TS, Nazarali AJ, Baker GB, Coutts RT. Chronic effects of tranylcypromine and 4-fluorotranylcypromine on regional brain monoamine metabolism in rats: a comparison with clorgyline. Biological Psychiatry. 25: 1014-20. PMID 2470425 DOI: 10.1016/0006-3223(89)90289-8  0.509
1988 Greenshaw AJ, Nazarali AJ, Rao TS, Baker GB, Coutts RT. Chronic tranylcypromine treatment induces functional alpha 2-adrenoceptor down-regulation in rats. European Journal of Pharmacology. 154: 67-72. PMID 2846327 DOI: 10.1016/0014-2999(88)90364-0  0.49
1987 Nazarali AJ, Baker GB, Coutts RT, Greenshaw AJ. Para-hydroxytranylcypromine: presence in rat brain and heart following administration of tranylcypromine and an N-cyanoethyl analogue. European Journal of Drug Metabolism and Pharmacokinetics. 12: 207-14. PMID 3436344 DOI: 10.1007/Bf03189899  0.513
Show low-probability matches.